Neurodegeneration with brain iron accumulation
Gene: C19orf12
Neurodegeneration with brain iron accumulation-4 (NBIA4) is a neurodegenerative disorder characterized by progressive spastic paraplegia, parkinsonism unresponsive to L-DOPA treatment, and psychiatric or behavioral symptoms. Other neurologic features, including optic atrophy, eye movement abnormalities, dystonia, dysphagia, dysarthria, and motor axonal neuropathy, may occur. Brain MRI shows T2-weighted hypointensities in the globus pallidus and substantia nigra. Onset is usually in the first 2 decades, but later onset has been reported. All pathogenic heterozygous mutations have occurred in exon 3, the last exon of C19ORF12, and have resulted in premature termination. Some cases presenting just with spastic paraplegia reported (e.g. PMID 20039086) but unclear if this truly represents a distinct disorder or milder phenotypic expression.Created: 14 Mar 2021, 1:21 a.m. | Last Modified: 14 Mar 2021, 1:21 a.m.
Panel Version: 0.3
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Neurodegeneration with brain iron accumulation 4, MIM# 614298; Spastic paraplegia 43, autosomal recessive, MIM# 615043
Publications
Gene: c19orf12 has been classified as Green List (High Evidence).
Phenotypes for gene: C19orf12 were changed from Mitochondrial membrane protein-associated neurodegeneration (MPAN) to Mitochondrial membrane protein-associated neurodegeneration (MPAN); Neurodegeneration with brain iron accumulation 4, MIM# 614298; Spastic paraplegia 43, autosomal recessive, MIM# 615043
Publications for gene: C19orf12 were set to
gene: C19orf12 was added gene: C19orf12 was added to Neuroferritinopathies. Sources: Expert Review Green,GeneReviews Mode of inheritance for gene: C19orf12 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Phenotypes for gene: C19orf12 were set to Mitochondrial membrane protein-associated neurodegeneration (MPAN)